EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Paradoxical action of PP2A inhibition and its potential for therapeutic sensitization

Yue Jiang iD, Ying Yuan, Guanglei Qiao, Zhoufeng Deng, Zimei Liu, Yan Zhang, Liping Yu, Hongjian Lin, Lijun Ma, Jianjun Zhang iD

Journal of Cellular Physiology · 2024-11 · 239 (11)

DOI: 10.1002/jcp.31413 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Cellular Physiology, online erschienen am 16.08.2024. Verfasst von Yue Jiang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Shanghai Tongren Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Protein Phosphatase 2, Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shanghai Science and Technology Innovation Action Plan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The protein phosphatase 2A (PP2A), a serine/threonine phosphatase, is recognized as a tumor suppressor involved in diverse cellular processes and essential for maintaining cell viability in vivo. However, endogenous inhibitors of PP2A such as cancerous inhibitor of PP2A (CIP2A) and endogenous nuclear protein inhibitor 2 of PP2A (SET) counteract the anticancer function of PP2A, promoting tumorigenesis, development, and drug resistance in tumors. Surprisingly though, contrary to conventional understanding, inhibition of the tumor suppressor gene PP2A with exogenous small molecule compounds can enhance the efficacy of cancer treatment and achieve superior tumor inhibition. Moreover, exogenous PP2A inhibitors resensitize cancers to treatment and provide novel therapeutic strategies for drug‐resistant tumors, which warrant further investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein Phosphatase 2NeoplasmsHumansAnimalsDrug Resistance, NeoplasmHistone ChaperonesAntineoplastic AgentsIntracellular Signaling Peptides and ProteinsEnzyme InhibitorsAutoantigensDNA-Binding ProteinsMembrane Proteins

Stichwörter der Autor:innen

DNA damagePP2A inhibitioncell cycle modulationcellular signal transductiondrug resistanceoncotherapy sensitization

Substanzen

Protein Phosphatase 2Histone ChaperonesAntineoplastic AgentsSET protein, humanIntracellular Signaling Peptides and ProteinsEnzyme InhibitorsCIP2A protein, humanAutoantigensDNA-Binding ProteinsMembrane Proteins

Autor:innen und Institutionen

  • Department of Oncology, Shanghai Tongren Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.

ORCID-Profile: Yue Jiang, Jianjun Zhang

Förderung

  • National Natural Science Foundation of China
  • Shanghai Science and Technology Innovation Action Plan

Zitieren

APA

Jiang, Y., Yuan, Y., Qiao, G., Deng, Z., Liu, Z., Zhang, Y., Yu, L., Lin, H., Ma, L., & Zhang, J. (2024). Paradoxical action of PP2A inhibition and its potential for therapeutic sensitization. Journal of Cellular Physiology, 239(11). https://doi.org/10.1002/jcp.31413

Vancouver

Jiang Y, Yuan Y, Qiao G, Deng Z, Liu Z, Zhang Y, et al. Paradoxical action of PP2A inhibition and its potential for therapeutic sensitization. Journal of Cellular Physiology. 2024;239(11). doi:10.1002/jcp.31413

BibTeX
@article{Jiang2024,
  author = {Jiang, Yue and Yuan, Ying and Qiao, Guanglei and Deng, Zhoufeng and Liu, Zimei and Zhang, Yan and Yu, Liping and Lin, Hongjian and Ma, Lijun and Zhang, Jianjun},
  title = {Paradoxical action of PP2A inhibition and its potential for therapeutic sensitization},
  journal = {Journal of Cellular Physiology},
  year = {2024},
  volume = {239},
  number = {11},
  doi = {10.1002/jcp.31413}
}
Kostenlos starten →